Ionis Pharmaceuticals Inc (IONS): Total Assets
$3.52B
As of 2025-12-31
$2.99B
As of 2026-06-30
+11.6%
3-year compound annual growth
+8.1%
5-year compound annual growth
+14.0%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.52B | +17.3% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $3.00B | +0.5% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $2.99B | +18.0% | 2025-02-19, Balance as of period end |
| 2022-12-31 | $2.53B | -3.0% | 2024-02-21, Balance as of period end |
| 2021-12-31 | $2.61B | +9.3% | 2023-02-22, Balance as of period end |
| 2020-12-31 | $2.39B | -26.1% | 2022-02-25, Balance as of period end |
| 2019-12-31 | $3.23B | +21.2% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $2.67B | +101.7% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $1.32B | +45.0% | 2019-03-01, Balance as of period end |
| 2016-12-31 | $912.47M | -3.7% | 2018-02-28, Balance as of period end |
| 2015-12-31 | $947.90M | -0.8% | 2017-03-01, Balance as of period end |
| 2014-12-31 | $955.81M | +12.8% | 2016-02-26, Balance as of period end |
| 2013-12-31 | $847.16M | +55.2% | 2015-03-02, Balance as of period end |
| 2012-12-31 | $545.69M | +12.5% | 2014-03-03, Balance as of period end |
| 2011-12-31 | $484.89M | -11.9% | 2013-02-28, Balance as of period end |
| 2010-12-31 | $550.48M | -16.2% | 2012-02-29, Balance as of period end |
| 2009-12-31 | $657.18M | n/a | 2011-03-01, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $3.52B | +17.3% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $1.26B | +20.9% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $1.44B | +12.1% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $1.27B | +27.3% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $1.56B | +31.7% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $1.39B | +21.5% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $3.49B | +2.7% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.66B | -0.4% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $836.65M | -0.5% |
Compare IONS, MDGL, ANIP, HRMY side by side · Screen every company in Pharmaceutical Preparations ↗